Go offline with the Player FM app!
135. Dr. Brooklyn Olumba (BRCA2 Mutation Carrier & 3-year Breast Cancer Survivor Diagnosed at Age 28)
Manage episode 361288455 series 2807692
On today’s episode, I am speaking with Dr. Brooklyn Olumba. Dr. Olumba is a clinical pharmacist, BRCA2 mutation carrier, and a 3-year breast cancer survivor who was diagnosed with stage 1B breast cancer at the age of 28 following an annual breast MRI at the start of the COVID-19 pandemic. She is passionate about genetic testing, patient advocacy, and using social media as tool to connect community members together. Brooklyn shares her experience navigating breast cancer during the pandemic, being a healthcare provider as a patient, the good and bad of social media, the importance of allowing yourself space to feel and react to emotions (while being ok having a temporary pity party!), the advocacy work she is doing, and where she is now. Find and follow her on Instagram at brooklyn_style!
167 episodes
Manage episode 361288455 series 2807692
On today’s episode, I am speaking with Dr. Brooklyn Olumba. Dr. Olumba is a clinical pharmacist, BRCA2 mutation carrier, and a 3-year breast cancer survivor who was diagnosed with stage 1B breast cancer at the age of 28 following an annual breast MRI at the start of the COVID-19 pandemic. She is passionate about genetic testing, patient advocacy, and using social media as tool to connect community members together. Brooklyn shares her experience navigating breast cancer during the pandemic, being a healthcare provider as a patient, the good and bad of social media, the importance of allowing yourself space to feel and react to emotions (while being ok having a temporary pity party!), the advocacy work she is doing, and where she is now. Find and follow her on Instagram at brooklyn_style!
167 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.